Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Zevra Therapeutics (ZVRA) Tax Rate (2016 - 2025)

Zevra Therapeutics' Tax Rate history spans 11 years, with the latest figure at 3.96% for Q4 2025.

  • For Q4 2025, Tax Rate rose 7942.0% year-over-year to 3.96%; the TTM value through Dec 2025 reached 3.98%, up 2103.0%, while the annual FY2025 figure was 3.98%, 2103.0% up from the prior year.
  • Tax Rate reached 3.96% in Q4 2025 per ZVRA's latest filing, down from 44.32% in the prior quarter.
  • In the past five years, Tax Rate ranged from a high of 44.32% in Q3 2025 to a low of 75.47% in Q4 2024.
  • Average Tax Rate over 5 years is 5.35%, with a median of 0.5% recorded in 2022.
  • The largest YoY upside for Tax Rate was 7942bps in 2025 against a maximum downside of -6208bps in 2025.
  • A 5-year view of Tax Rate shows it stood at 1.27% in 2021, then surged by 189bps to 1.13% in 2022, then tumbled by -254bps to 1.74% in 2023, then tumbled by -4245bps to 75.47% in 2024, then skyrocketed by 105bps to 3.96% in 2025.
  • Per Business Quant, the three most recent readings for ZVRA's Tax Rate are 3.96% (Q4 2025), 44.32% (Q3 2025), and 2.86% (Q2 2025).